Bunion correction systems market seen reaching $1.22 billion by 2030

The Business Research Company says the global bunion correction systems market is expanding on rising arthritis cases, more orthopedic surgeries and growing demand for minimally invasive care. The market is projected to grow from $0.84 billion in 2025 to $0.91 billion in 2026, then reach $1.22 billion by 2030.

Why it matters: - The bunion correction systems market is tied to foot deformity treatment, surgical recovery and mobility outcomes for patients with hallux valgus and arthritis-related foot problems. - Demand is rising as aging populations increase arthritis and rheumatoid arthritis cases, adding pressure on orthopedic care systems. - Growth in minimally invasive surgery and advanced implants could reshape where and how bunion procedures are performed.

What happened: - The Business Research Company released its Bunion Correction Systems Market Report 2026, covering market size, trends and a global forecast through 2035. - The report pegs the market at $0.84 billion in 2025 and $0.91 billion in 2026, equal to 8.0% annual growth. - The market is forecast to reach $1.22 billion by 2030 at a 7.7% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period.

The details: - Bunion correction systems include medical devices and surgical instruments used to realign the metatarsophalangeal joint, stabilize bone structures and correct deformities caused by hallux valgus. - The systems are used in minimally invasive and open surgeries to reduce pain, restore foot function and prevent further complications. - Historical growth has been supported by continued use of osteotomy and exostectomy, limited availability of specialized correction devices, more orthopedic surgeries, rising hallux valgus prevalence and hospital-based procedures. - Future growth drivers include advanced implants, wearable correction technologies, ambulatory and specialized care centers, digital imaging, surgical planning tools and faster-recovery expectations. - The report highlights increasing adoption of minimally invasive correction methods, stronger demand for implants and accessories, more specialty foot care facilities, post-operative rehabilitation and broader focus on foot health and orthopedic care. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample report is available here. - The full report is available here.

Between the lines: - Arthritis is emerging as a key demand driver because joint degeneration and autoimmune inflammation often increase the need for surgical foot correction. - Arthritis Australia reported in February 2024 that about 15% of Australians across all age groups live with arthritis. - Arthritis Australia projects the arthritis population in Australia will rise 31% by 2040 to 5.39 million people, up by 1.28 million. - The same projection puts rheumatoid arthritis cases at about 280,040 males and 479,828 females by 2040. - The regional split suggests mature markets are still dominant, while faster growth in Asia-Pacific points to expanding access and procedure volumes there.

What's next: - The market is likely to keep shifting toward minimally invasive systems, digital planning and specialty care settings. - Providers and device makers will likely focus on faster recovery, better implants and rehabilitation support as patient expectations rise. - The report also includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, hotspots infographics and updated graphics and tables.

The bottom line: - Bunion correction systems are moving from a niche surgical category into a steadier growth market, driven by aging-related joint disease, procedural innovation and stronger demand for recovery-focused care.